hVIVO Plc (HVO):企業の財務・戦略的SWOT分析

◆英語タイトル:hVIVO Plc (HVO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH194967FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥90,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥135,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
hVIVO Plc (hVIVO), formerly Retroscreen Virology Ltd is a biopharma company that develops human-based analytical platform to accelerate drug discovery and development. The company enables organisations to discover drugs and diagnostics and accelerate new product development. It uses human disease model platform to study new drugs and investigate diseases. hVIVO offers services such as viral challenge study services, viral lab services, and target and biomarker discovery. The company offers lab services in the areas of virology, immunology and molecular biology. Its disease models comprise influenza research, human rhinoviruses research, respiratory syncytial virus research, and asthma research. The company serves pharmaceutical and biotech companies across the UK. hVIVO is headquartered in London, the UK.

hVIVO Plc Key Recent Developments

Mar 26,2021: Open Orphan: £7.5m human challenge study contract
Oct 20,2020: Open Orphan/hVIVO signs contract with UK Government for the development of a covid-19 human challenge study model
Sep 07,2020: hVIVO to present at the upcoming 2020 European Respiratory Society (ERS) International Congress

This comprehensive SWOT profile of hVIVO Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of hVIVO Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

hVIVO Plc – Key Information
hVIVO Plc – Overview
hVIVO Plc – Key Employees
hVIVO Plc – Key Employee Biographies
hVIVO Plc – Key Operational Heads
hVIVO Plc – Major Products and Services
hVIVO Plc – History
hVIVO Plc – Company Statement
hVIVO Plc – Locations And Subsidiaries
hVIVO Plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

hVIVO Plc – Business Description
hVIVO Plc – Corporate Strategy
hVIVO Plc – SWOT Analysis
SWOT Analysis – Overview
hVIVO Plc – Strengths
hVIVO Plc – Weaknesses
hVIVO Plc – Opportunities
hVIVO Plc – Threats
hVIVO Plc – Key Competitors

Section 3 – Company Financial Performance Charts

hVIVO Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

hVIVO Plc, Key Information
hVIVO Plc, Key Ratios
hVIVO Plc, Share Data
hVIVO Plc, Major Products and Services
hVIVO Plc, History
hVIVO Plc, Key Employees
hVIVO Plc, Key Employee Biographies
hVIVO Plc, Key Operational Heads
hVIVO Plc, Other Locations
hVIVO Plc, Subsidiaries
hVIVO Plc, Key Competitors
hVIVO Plc, SWOT Analysis
hVIVO Plc, Ratios based on current share price
hVIVO Plc, Annual Ratios
hVIVO Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[hVIVO Plc (HVO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Brazil Fast Food Corp.:企業の戦略・SWOT・財務情報
    Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report Summary Brazil Fast Food Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Powszechny Zaklad Ubezpieczen Group:企業の戦略・SWOT・財務情報
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Interglobe Aviation Limited:企業の戦略・SWOT・財務情報
    Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report Summary Interglobe Aviation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Idemitsu Kosan Co., Ltd.:企業の戦略・SWOT・財務分析
    Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Idemitsu Kosan Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • InterHealth Nutraceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary InterHealth Nutraceuticals Inc (InterHealth), a subsidiary of Lonza Group Ltd, is a developer, manufacturer and distributor of nutraceutical ingredients. The company offers nutritional ingredients such as Zychrome, Meratrim, LOWAT, Super CitriMax, ChromeMate, L-OptiZinc, Protykin, ZMA, UC-II …
  • Enbridge Inc (ENB):石油・ガス:M&Aディール及び事業提携情報
    Summary Enbridge Inc (Enbridge) is an integrated energy company. It carries out natural gas gathering, processing, transmission and distribution; transportation of crude oil; and marketing of petroleum products. The company also involved in power generation and transmission and has interests in rene …
  • Vectrus Inc (VEC):企業の財務・戦略的SWOT分析
    Vectrus Inc (VEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • LI-COR Inc-製薬・医療分野:企業M&A・提携分析
    Summary LI-COR Inc (LCB), doing business as LI-COR Biosciences is a medical device company that offers research services. The company offers scientific instruments for plant science research. It designs, manufactures and markets instruments, software, reagents, and integrated systems for biotechnolo …
  • Genome Institute of Singapore-医療機器分野:企業M&A・提携分析
    Summary Genome Institute of Singapore (GIS) is a research institute that provides various research programs and services in different areas. The institute concentrates on genomic sciences to improve public health and prosperity in Singapore. It handles the latest in technology and comprises early ca …
  • Motiva Enterprises LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Motiva Enterprises LLC (Motiva), a subsidiary of Saudi Refining, Inc., is downstream oil and gas company, which refines, distributes and markets fuels. The company refines and produces commercial aviation fuel, conventional gasoline, high cetane diesel, ultra-low sulfur diesel, base oils, co …
  • Calpine Corp:企業の戦略的SWOT分析
    Calpine Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • SymBio Pharmaceuticals Ltd (4582):企業の財務・戦略的SWOT分析
    Summary SymBio Pharmaceuticals Ltd (SymBio) is a biopharmaceutical company that develops and markets anti-cancer drug candidates. Its pipeline product portfolio includes Treakisym (SyB L-0501), an anti-cancer agent used for the treatment of non-Hodgkin's lymphoma (NHL), multiple myeloma (MM) and chr …
  • Jersey Oil and Gas Plc (JOG):石油・ガス:M&Aディール及び事業提携情報
    Summary Jersey Oil and Gas Plc (Jersey Oil), formerly Trap Oil Group Plc is an upstream oil and gas exploration and production company. The company acquires, explores, develops and produces natural gas properties in the UK continental shelf. Its oil and gas properties include Homer Block, Cortina Bl …
  • H. Lundbeck AS (LUN)-製薬・医療分野:企業M&A・提携分析
    Summary H. Lundbeck A/S (Lundbeck), a subsidiary of The Lundbeck Foundation carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) related diseases including psychiatric and neurological disorders. Its products are …
  • First Solar Inc (FSLR):電力:M&Aディール及び事業提携情報
    Summary First Solar Inc (First Solar) is a provider of comprehensive photovoltaic (PV) solar systems. It designs, manufactures, and sells PV solar modules. The company produces solar systems using cadmium telluride technology. First Solar also develops, designs, constructs, and sells PV solar power …
  • NuVista Energy Ltd (NVA):石油・ガス:M&Aディール及び事業提携情報
    Summary NuVista Energy Ltd (NuVista) is an oil and gas company that offers exploration, development and production of oil and natural gas reserves. The company conducts its operations in Western Canadian Sedimentary Basin which is located in West Central Alberta and Northeast British Columbia areas …
  • Marshall of Cambridge (Holdings) Ltd:企業の戦略的SWOT分析
    Marshall of Cambridge (Holdings) Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • CBRE Global Investors LLC:企業の戦略的SWOT分析
    CBRE Global Investors LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Ubiquiti Networks Inc
    Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report Summary Ubiquiti Networks Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Orphazyme AS (ORPHA):製薬・医療:M&Aディール及び事業提携情報
    Summary Orphazyme A/S (Orphazyme) formerly Orphazyme ApS, is a biopharmaceutical company that develops heat shock protein based therapies for the treatment of orphan protein-misfolding diseases. Its lead product drug candidate arimoclomol is under clinical development for treating neuromuscular dise …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆